Global and United States Immuno-Oncology Treatment Market Report & Forecast 2022-2028
SKU ID : QYR-20785886 | Publishing Date : 25-Apr-2022
Detailed TOC of Global and United States Immuno-Oncology Treatment Market Report & Forecast 2022-2028
1 Study Coverage1.1 Immuno-Oncology Treatment Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Immuno-Oncology Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Immuno-Oncology Treatment Market Size for the Year 2017-2028
1.2.2 Global Immuno-Oncology Treatment Market Size for the Year 2017-2028
1.3 Immuno-Oncology Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Immuno-Oncology Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Immuno-Oncology Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Immuno-Oncology Treatment Market Dynamics
1.4.1 Immuno-Oncology Treatment Industry Trends
1.4.2 Immuno-Oncology Treatment Market Drivers
1.4.3 Immuno-Oncology Treatment Market Challenges
1.4.4 Immuno-Oncology Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Immuno-Oncology Treatment by Type
2.1 Immuno-Oncology Treatment Market Segment by Type
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Monoclonal Antibodies
2.1.3 Cytokine-Based Immunotherapy
2.1.4 Cancer Vaccines
2.1.5 CAR-T Cell Therapy
2.2 Global Immuno-Oncology Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Immuno-Oncology Treatment Market Size by Type (2017-2028)
2.4 United States Immuno-Oncology Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Immuno-Oncology Treatment Market Size by Type (2017-2028)
3 Immuno-Oncology Treatment by Application
3.1 Immuno-Oncology Treatment Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Center
3.1.3 Others
3.2 Global Immuno-Oncology Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Immuno-Oncology Treatment Market Size by Application (2017-2028)
3.4 United States Immuno-Oncology Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Immuno-Oncology Treatment Market Size by Application (2017-2028)
4 Global Immuno-Oncology Treatment Competitor Landscape by Company
4.1 Global Immuno-Oncology Treatment Market Size by Company
4.1.1 Top Global Immuno-Oncology Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Immuno-Oncology Treatment Revenue by Player (2017-2022)
4.2 Global Immuno-Oncology Treatment Concentration Ratio (CR)
4.2.1 Immuno-Oncology Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Immuno-Oncology Treatment in 2021
4.2.3 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Immuno-Oncology Treatment Headquarters, Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Immuno-Oncology Treatment Headquarters and Area Served
4.3.2 Global Immuno-Oncology Treatment Companies Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Immuno-Oncology Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Immuno-Oncology Treatment Market Size by Company
4.5.1 Top Immuno-Oncology Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Immuno-Oncology Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Immuno-Oncology Treatment Market Size by Region
5.1 Global Immuno-Oncology Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Immuno-Oncology Treatment Market Size by Region (2017-2028)
5.2.1 Global Immuno-Oncology Treatment Market Size by Region: 2017-2022
5.2.2 Global Immuno-Oncology Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Immuno-Oncology Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Immuno-Oncology Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Immuno-Oncology Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Immuno-Oncology Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Immuno-Oncology Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Immuno-Oncology Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Company Details
7.1.2 Amgen Business Overview
7.1.3 Amgen Immuno-Oncology Treatment Introduction
7.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.1.5 Amgen Recent Development
7.2 AstraZeneca
7.2.1 AstraZeneca Company Details
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Immuno-Oncology Treatment Introduction
7.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.2.5 AstraZeneca Recent Development
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Details
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction
7.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.3.5 Bristol-Myers Squibb Recent Development
7.4 Eli-Lilly
7.4.1 Eli-Lilly Company Details
7.4.2 Eli-Lilly Business Overview
7.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction
7.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.4.5 Eli-Lilly Recent Development
7.5 Roche
7.5.1 Roche Company Details
7.5.2 Roche Business Overview
7.5.3 Roche Immuno-Oncology Treatment Introduction
7.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.5.5 Roche Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Details
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction
7.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.6.5 GlaxoSmithKline Recent Development
7.7 Janssen Biotech
7.7.1 Janssen Biotech Company Details
7.7.2 Janssen Biotech Business Overview
7.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction
7.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.7.5 Janssen Biotech Recent Development
7.8 Merck
7.8.1 Merck Company Details
7.8.2 Merck Business Overview
7.8.3 Merck Immuno-Oncology Treatment Introduction
7.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.8.5 Merck Recent Development
7.9 Novartis
7.9.1 Novartis Company Details
7.9.2 Novartis Business Overview
7.9.3 Novartis Immuno-Oncology Treatment Introduction
7.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.9.5 Novartis Recent Development
7.10 Pfizer
7.10.1 Pfizer Company Details
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Immuno-Oncology Treatment Introduction
7.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.10.5 Pfizer Recent Development
7.11 Sanofi
7.11.1 Sanofi Company Details
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Immuno-Oncology Treatment Introduction
7.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.11.5 Sanofi Recent Development
7.12 Spectrum Pharmaceuticals
7.12.1 Spectrum Pharmaceuticals Company Details
7.12.2 Spectrum Pharmaceuticals Business Overview
7.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction
7.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.12.5 Spectrum Pharmaceuticals Recent Development
7.13 Takeda
7.13.1 Takeda Company Details
7.13.2 Takeda Business Overview
7.13.3 Takeda Immuno-Oncology Treatment Introduction
7.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022)
7.13.5 Takeda Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Immuno-Oncology Treatment Market Report & Forecast 2022-2028
List of TablesTable 1. Immuno-Oncology Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Immuno-Oncology Treatment Market Trends
Table 3. Immuno-Oncology Treatment Market Drivers
Table 4. Immuno-Oncology Treatment Market Challenges
Table 5. Immuno-Oncology Treatment Market Restraints
Table 6. Global Immuno-Oncology Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Immuno-Oncology Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Immuno-Oncology Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Immuno-Oncology Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Immuno-Oncology Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Immuno-Oncology Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Immuno-Oncology Treatment Revenue Share by Player, 2017-2022
Table 13. Global Immuno-Oncology Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2021)
Table 15. Top Players of Immuno-Oncology Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Immuno-Oncology Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Immuno-Oncology Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Immuno-Oncology Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Immuno-Oncology Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Immuno-Oncology Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Immuno-Oncology Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Immuno-Oncology Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Immuno-Oncology Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Amgen Company Details
Table 31. Amgen Business Overview
Table 32. Amgen Immuno-Oncology Treatment Product
Table 33. Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 34. Amgen Recent Development
Table 35. AstraZeneca Company Details
Table 36. AstraZeneca Business Overview
Table 37. AstraZeneca Immuno-Oncology Treatment Product
Table 38. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 39. AstraZeneca Recent Development
Table 40. Bristol-Myers Squibb Company Details
Table 41. Bristol-Myers Squibb Business Overview
Table 42. Bristol-Myers Squibb Immuno-Oncology Treatment Product
Table 43. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 44. Bristol-Myers Squibb Recent Development
Table 45. Eli-Lilly Company Details
Table 46. Eli-Lilly Business Overview
Table 47. Eli-Lilly Immuno-Oncology Treatment Product
Table 48. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 49. Eli-Lilly Recent Development
Table 50. Roche Company Details
Table 51. Roche Business Overview
Table 52. Roche Immuno-Oncology Treatment Product
Table 53. Roche Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 54. Roche Recent Development
Table 55. GlaxoSmithKline Company Details
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Immuno-Oncology Treatment Product
Table 58. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 59. GlaxoSmithKline Recent Development
Table 60. Janssen Biotech Company Details
Table 61. Janssen Biotech Business Overview
Table 62. Janssen Biotech Immuno-Oncology Treatment Product
Table 63. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 64. Janssen Biotech Recent Development
Table 65. Merck Company Details
Table 66. Merck Business Overview
Table 67. Merck Immuno-Oncology Treatment Product
Table 68. Merck Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Immuno-Oncology Treatment Product
Table 73. Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Immuno-Oncology Treatment Product
Table 78. Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. Sanofi Company Details
Table 81. Sanofi Business Overview
Table 82. Sanofi Immuno-Oncology Treatment Product
Table 83. Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 84. Sanofi Recent Development
Table 85. Spectrum Pharmaceuticals Company Details
Table 86. Spectrum Pharmaceuticals Business Overview
Table 87. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product
Table 88. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 89. Spectrum Pharmaceuticals Recent Development
Table 90. Takeda Company Details
Table 91. Takeda Business Overview
Table 92. Takeda Immuno-Oncology Treatment Product
Table 93. Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 94. Takeda Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Immuno-Oncology Treatment Product Picture
Figure 2. Global Immuno-Oncology Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Immuno-Oncology Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Immuno-Oncology Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Immuno-Oncology Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Immuno-Oncology Treatment Market Share in Global 2017-2028
Figure 7. Immuno-Oncology Treatment Report Years Considered
Figure 8. Product Picture of Immune Checkpoint Inhibitors
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Cytokine-Based Immunotherapy
Figure 11. Product Picture of Cancer Vaccines
Figure 12. Product Picture of CAR-T Cell Therapy
Figure 13. Global Immuno-Oncology Treatment Market Share by Type in 2022 & 2028
Figure 14. Global Immuno-Oncology Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Immuno-Oncology Treatment Market Share by Type (2017-2028)
Figure 16. United States Immuno-Oncology Treatment Market Share by Type in 2022 & 2028
Figure 17. United States Immuno-Oncology Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Immuno-Oncology Treatment Market Share by Type (2017-2028)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Ambulatory Surgical Center
Figure 21. Product Picture of Others
Figure 22. Global Immuno-Oncology Treatment Market Share by Application in 2022 & 2028
Figure 23. Global Immuno-Oncology Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Immuno-Oncology Treatment Market Share by Application (2017-2028)
Figure 25. United States Immuno-Oncology Treatment Market Share by Application in 2022 & 2028
Figure 26. United States Immuno-Oncology Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Immuno-Oncology Treatment Market Share by Application (2017-2028)
Figure 28. North America Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 57. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 59. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 62. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 63. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 64. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 66. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 67. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 68. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Keyplayers in Global and United States Immuno-Oncology Treatment Market Report & Forecast 2022-2028
AmgenAstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda